Cytokines as biomarkers in rheumatoid arthritis

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Burska, Agata ^a   Boissinot, Marjorie ^a   Ponchel, Frederique ^a,b,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; AUTOANTIBODY;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CIRCADIAN RHYTHM; CYTOKINE PRODUCTION; EARLY DIAGNOSIS; EXERCISE; HUMAN; NONHUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; STRESS; ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 84897551359     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/545493     Document Type: Review

References (245)

1. Avouac J., Gossec L., Dougados M., Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in Rheumatoid Arthritis: a systematic literature review. Annals of the Rheumatic Diseases 2006 65 7 845 851 2-s2.0-33745725970 10.1136/ard.2006.051391
2. Goëb V., Aegerter P., Parmar R., Progression to Rheumatoid Arthritis in early inflammatory arthritis is associated with low IL-7 serum levels. Annals of the Rheumatic Diseases 2013 72 6 1032 1036 10.1136/annrheumdis-2012- 202377
3. Gerlag D. M., Raza K., van Baarsen L. G. M., Brouwer E., Buckley C. D., Burmester G. R., Gabay C., Catrina A. I., Cope A. P., Cornelis F., Dahlqvist S. R., Emery P., Eyre S., Finckh A., Gay S., Hazes J. M., van der Helm-Van Mil A., Huizinga T. W. J., Klareskog L., Kvien T. K., Lewis C., Machold K. P., Rönnelid J., van Schaardenburg D., Schett G., Smolen J. S., Thomas S., Worthington J., Tak P. P., EULAR recommendations for terminology and research in individuals at risk of Rheumatoid Arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Annals of the Rheumatic Diseases 2012 71 5 638 641 2-s2.0-84859487325 10.1136/annrheumdis-2011-200990
4. Shi J., Knevel R., Suwannalai P., van der Linden M. P., Janssen G. M. C., van Veelen P. A., Levarht N. E. W., van der Helm-Van Mil A. H. M., Cerami A., Huizinga T. W. J., Toes R. E. M., Trouw L. A., Autoantibodies recognizing carbamylated proteins are present in sera of patients with Rheumatoid Arthritis and predict joint damage. Proceedings of the National Academy of Sciences of the United States of America 2011 108 42 17372 17377 2-s2.0-80054806901 10.1073/pnas.1114465108
5. Shi J., Willemze A., Janssen G. M. C., Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the "AMC-Senshu" method. Annals of the Rheumatic Diseases 2013 72 1 148 150 10.1136/annrheumdis-2012-201559
6. Aletaha D., Neogi T., Silman A. J., Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis & Rheumatism 2010 62 9 2569 2581 10.1002/art.27584
7. Burgoyne C., Vital E., Dass S., Corscadden D., Emery P., Ponchel F., Alteration of B cell phenotype following depletion with rituximab in Rheumatoid Arthritis. Proceedings of the 28th European Workshop for Rheumatology Research (EWRR '08) 2008 Toulouse, France
8. Saleem B., Keen H., Goeb V., Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped? Annals of the Rheumatic Diseases 2010 69 9 1636 1642 10.1136/ard.2009.117341
9. Ponchel F., Goëb V., Parmar R., El-Sherbiny Y., Boissinot M., El Jawhari J., Burska A., Vital E. M., Harrison S., Conaghan P. G., Hensor E., Emery P., An immunological biomarker to predict MTX response in early RA. Annals of the Rheumatic Diseases 2013 10.1136/annrheumdis-2013-203566
10. Ramiro S., Machado P., Singh J. A., Landewé R. B., da Silva J. A. P., Applying science in practice: the optimization of biological therapy in Rheumatoid Arthritis. Arthritis Research & Therapy 2010 12 6, article 220 2-s2.0-79955635210 10.1186/ar3149
11. Fueldner C., Mittag A., Knauer J., Biskop M., Hepp P., Scholz R., Wagner U., Sack U., Emmrich F., Tárnok A., Lehmann J., Identification and evaluation of novel synovial tissue biomarkers in Rheumatoid Arthritis by laser scanning cytometry. Arthritis Research & Therapy 2012 14 1, article R8 2-s2.0-84855765091 10.1186/ar3682
12. Churchman S. M., Geiler J., Parmar R., Horner E. A., Church L. D., Emery P., Buch M. H., McDermott M. F., Ponchel F., Multiplexing immunoassays for cytokine detection in the serum of patients with Rheumatoid Arthritis: lack of sensitivity and interference by rheumatoid factor. Clinical and Experimental Rheumatology 2012 30 4 534 542
13. Prince A. M., Brotman B., Jass D., Ikram H., Specificity of the direct solid-phase radioimmunoassay for detection of hepatitis-B antigen. The Lancet 1973 1 7816 1346 1350 2-s2.0-0015927544
14. Hunter W. M., Budd P. S., Circulating antibodies to ovine and bovine immunoglobulin in healthy subjects: a hazard for immunoassays. The Lancet 1980 2 8204 1136 2-s2.0-0019330991 10.1016/S0140-6736(80)92565-9
15. Howanitz P. J., Howanitz J. H., Lamberson H. V., Ennis K. M., Incidence and mechanism of spurious increases in serum thyrotropin. Clinical Chemistry 1982 28 3 427 431 2-s2.0-0020054134 (Pubitemid 12145602)
16. Zweig M. H., Csako G., Benson C. C., Weintraub B. D., Kahn B. B., Interference by anti-immunoglobulin G antibodies in immunoradiometric assays of thyrotropin involving mouse monoclonal antibodies. Clinical Chemistry 1987 33 6 840 844 2-s2.0-0023359668
17. Benoist J.-F., Orbach D., Biou D., False increase in C-reactive protein attributable to heterophilic antibodies in two renal transplant patients treated with rabbit antilymphocyte globulin. Clinical Chemistry 1998 44 9 1980 1985 2-s2.0-0031754143 (Pubitemid 28405766)
18. Boscato L. M., Stuart M. C., Heterophilic antibodies: a problem for all immunoassays. Clinical Chemistry 1988 34 1 27 33 2-s2.0-0023853204 (Pubitemid 18039404)
19. Nahm M. H., Hoffmann J. W., Heteroantibody: phantom of the immunoassay. Clinical Chemistry 1990 36 6 829 2-s2.0-0025346125 (Pubitemid 20189246)
20. Martins T. B., Development of internal controls for the Luminex instrument as part of a multiplex seven-analyte viral respiratory antibody profile. Clinical and Diagnostic Laboratory Immunology 2002 9 1 41 45 2-s2.0-0036146140 10.1128/CDLI.9.1.41-45.2002 (Pubitemid 34084273)
21. de Jager W., Prakken B. J., Bijlsma J. W. J., Kuis W., Rijkers G. T., Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. Journal of Immunological Methods 2005 300 1-2 124 135 2-s2.0-20444409138 10.1016/j.jim.2005.03.009 (Pubitemid 40805593)
22. de Jager W., Rijkers G. T., Solid-phase and bead-based cytokine immunoassay: a comparison. Methods 2006 38 4 294 303 2-s2.0-33644952039 10.1016/j.ymeth.2005.11.008
23. Hueber W., Tomooka B. H., Zhao X., Kidd B. A., Drijfhout J. W., Fries J. F., van Venrooij W. J., Metzger A. L., Genovese M. C., Robinson W. H., Proteomic analysis of secreted proteins in early Rheumatoid Arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Annals of the Rheumatic Diseases 2007 66 6 712 719 2-s2.0-34249827580 10.1136/ard.2006.054924 (Pubitemid 46846688)
24. Longmore M., Wilkinson I., Davidson E., Foulkes A., Mafi A., Oxford Handbook of Clinical Medicine 2010 Oxford University Press
25. Agnello V., Arbetter A., de Kasep G. I., Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype. Journal of Experimental Medicine 1980 151 6 1514 1527 2-s2.0-0018870012 (Pubitemid 10062947)
26. Thavasu P. W., Longhurst S., Joel S. P., Slevin M. L., Balkwill F. R., Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. Journal of Immunological Methods 1992 153 1-2 115 124 2-s2.0-0026781419
27. Wong H.-L., Pfeiffer R. M., Fears T. R., Vermeulen R., Ji S., Rabkin C. S., Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiology Biomarkers & Prevention 2008 17 12 3450 3456 2-s2.0-57449084708 10.1158/1055-9965.EPI-08-0311
28. Patil R., Shukre S., Paranjape R., Thakar M., Heparin and EDTA anticoagulants differentially affect the plasma cytokine levels in humans. Scandinavian Journal of Clinical & Laboratory Investigation 2013 73 5 452 455 10.3109/00365513.2013.798869
29. Jackman R. P., Utter G. H., Heitman J. W., Hirschkorn D. F., Law J. P., Gefter N., Busch M. P., Norris P. J., Effects of blood sample age at time of separation on measured cytokine concentrations in human plasma. Clinical and Vaccine Immunology 2011 18 2 318 326 2-s2.0-79551494483 10.1128/CVI.00465-10
30. Skogstrand K., Ekelund C. K., Thorsen P., Vogel I., Jacobsson B., Nørgaard-Pedersen B., Hougaard D. M., Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. Journal of Immunological Methods 2008 336 1 78 84 2-s2.0-43849092496 10.1016/j.jim.2008.04.006
31. Riches P., Gooding R., Millar B. C., Rowbottom A. W., Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF- α concentrations. Journal of Immunological Methods 1992 153 1-2 125 131 2-s2.0-0026702473
32. Leroux-Roels G., Philippe J., Offner F., Vermeulen A., In-vitro production of cytokines in blood. The Lancet 1990 336 8724 1197 2-s2.0-0025054444 10.1016/0140-6736(90)92819-4 (Pubitemid 20362956)
33. Biancotto A., Feng X., Langweiler M., Young N. S., McCoy J. P., Effect of anticoagulants on multiplexed measurement of /chemokines in healthy subjects. Cytokine 2012 60 2 438 446 10.1016/j.cyto.2012.05.019
34. Flower L., Ahuja R. H., Humphries S. E., Mohamed-Ali V., Effects of sample handling on the stability of interleukin 6, tumour necrosis factor- α and leptin. Cytokine 2000 12 11 1712 1716 2-s2.0-0033671464 10.1006/cyto.2000.0764
35. de Jongh R., Vranken J., Vundelinckx G., Bosmans E., Maes M., Heylen R., The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor. Cytokine 1997 9 9 696 701 2-s2.0-0031238608 10.1006/cyto.1997.0217 (Pubitemid 27399837)
36. Eggesbø J. B., Hjermann I., Høstmark A. T., Kierulf P., LPS induced release of IL-1 β IL-6, IL-8 and TNF- α in EDTA or heparin anticoagulated whole blood from persons with high or low levels of serum HDL. Cytokine 1996 8 2 152 160 2-s2.0-0029970407 10.1006/cyto.1996.0022 (Pubitemid 26109154)
37. Kenis G., Teunissen C., de Jongh R., Bosmans E., Steinbusch H., Maes M., Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine 2002 19 5 228 235 2-s2.0-0036035313 10.1016/S1043-4666(02)91961-7 (Pubitemid 35257822)
38. Read S. W., Rupert A., Stevens R., O'Shea A., Sereti I., Delayed sample processing leads to marked decreases in measured plasma IL-7 levels. Journal of Acquired Immune Deficiency Syndromes 2006 42 4 511 512 2-s2.0-33745920794 10.1097/01.qai.0000225741.16840.ac (Pubitemid 44050903)
39. Aziz N., Nishanian P., Mitsuyasu R., Detels R., Fahey J. L., Variables that affect assays for plasma cytokines and soluble activation markers. Clinical and Diagnostic Laboratory Immunology 1999 6 1 89 95 2-s2.0-0032946346 (Pubitemid 29035646)
40. Lengellé J., Panopoulos E., Betsou F., Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum. Cytokine 2008 44 2 275 282 2-s2.0-56049101835 10.1016/j.cyto.2008.08.010
41. Redl H., Bahrami S., Leichtfried G., Schlag G., Special collection and storage tubes for blood endotoxin and cytokine measurements. Clinical Chemistry 1992 38 5 764 765 2-s2.0-0026724784
42. Exley A. R., Cohen J., Optimal collection of blood samples for the measurement of tumor necrosis factor α Cytokine 1990 2 5 353 356 2-s2.0-0025488150
43. Leroux-Roels G., Offner F., Philippe J., Vermeulen A., Influence of blood-collecting systems on concentrations of tumor necrosis factor in serum and plasma. Clinical Chemistry 1988 34 11 2373 2374 2-s2.0-0024237753 (Pubitemid 19001283)
44. Zimmermann R., Koenig J., Zingsem J., Weisbach V., Strasser E., Ringwald J., Eckstein R., Effect of specimen anticoagulation on the measurement of circulating platelet-derived growth factors. Clinical Chemistry 2005 51 12 2365 2368 2-s2.0-28044461712 10.1373/clinchem.2005.055558 (Pubitemid 41692585)
45. Grainger D. J., Mosedale D. E., Metcalfe J. C., TGF- β in blood: a complex problem. Cytokine & Growth Factor Reviews 2000 11 1-2 133 145 2-s2.0-0034022167 10.1016/S1359-6101(99)00037-4 (Pubitemid 30169734)
46. Kropf J., Schurek J. O., Wollner A., Gressner A. M., Immunological measurement of transforming growth factor-beta I (TGF- β 1) in blood; assay development and comparison. Clinical Chemistry 1997 43 10 1965 1974 2-s2.0-0030776705 (Pubitemid 27452289)
47. Wakefield L. M., Letterio J. J., Chen T., Danielpour D., Allison R. S. H., Pai L. H., Denicoff A. M., Noone M. H., Cowan K. H., O'Shaughnessy J. A., Sporn M. B., Transforming growth factor- β 1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clinical Cancer Research 1995 1 1 129 136 2-s2.0-0028942671
48. Chaigneau C., Cabioch T., Beaumont K., Betsou F., Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variation. Clinical Chemistry and Laboratory Medicine 2007 45 10 1390 1395 2-s2.0-35048878642 10.1515/CCLM.2007.160 (Pubitemid 47557062)
49. Zhao L., Wang L., Ji W., Lei M., Yang W., Kong F.-M., The influence of the blood handling process on the measurement of circulating TGF- β 1. European Cytokine Network 2012 23 1 1 6 2-s2.0-84859307803 10.1684/ecn.2012.0298
50. Halldórsdóttir A. M., Stoker J., Porche-Sorbet R., Eby C. S., Soluble CD40 ligand measurement inaccuracies attributable to specimen type, processing time, and ELISA method. Clinical Chemistry 2005 51 6 1054 1057 2-s2.0-19644369419 10.1373/clinchem.2005.048199 (Pubitemid 40740898)
51. Bereczki D., Nagy E., Pál A., Magyar M. T., Balla J., Blake G. J., Ostfeld R. J., Yucel E. K., Varo N., Schonbeck U., Blake M. A., Gerhard M., Ridker P. M., Libby P., Lee R. T., Should soluble CD40 ligand be measured from serum or plasma samples? Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 6 1129 1131 2-s2.0-12444253906 10.1161/01.ATV.0000072368.37740.8E (Pubitemid 36713573)
52. Varo N., Nuzzo R., Natal C., Libby P., Schönbeck U., Influence of pre-analytical and analytical factors on soluble CD40L measurements. Clinical Science 2006 111 5 341 347 2-s2.0-33750607885 10.1042/CS20060047 (Pubitemid 44690192)
53. Malone D., Napolitano L. M., Genuit T., Bochicchio G. V., Kole K., Scalea T. M., Total cytokine immunoassay: a more accurate method of cytokine measurement? The Journal of Trauma 2001 50 5 821 825 2-s2.0-0034990039 (Pubitemid 32499605)
54. Banks R. E., Measurement of cytokines in clinical samples using immunoassays: problems and pitfalls. Critical Reviews in Clinical Laboratory Sciences 2000 37 2 131 182 2-s2.0-0034019946 (Pubitemid 30258831)
55. Wadhwa M., Thorpe R., Cytokine immunoassays: recommendations for standardisation, calibration and validation. Journal of Immunological Methods 1998 219 1-2 1 5 2-s2.0-0031733504 10.1016/S0022-1759(98)00093-3 (Pubitemid 28513148)
56. Shurin G. V., Yurkovetsky Z. R., Chatta G. S., Tourkova I. L., Shurin M. R., Lokshin A. E., Dynamic alteration of soluble serum biomarkers in healthy aging. Cytokine 2007 39 2 123 129 2-s2.0-34848843438 10.1016/j.cyto.2007.06.006 (Pubitemid 47513836)
57. Bruunsgaard H., Pedersen B. K., Age-related inflammatory cytokines and disease. Immunology and Allergy Clinics of North America 2003 23 1 15 39 (Pubitemid 36268302)
58. Bruunsgaard H., Pedersen M., Pedersen B. K., Aging and proinflammatory cytokines. Current Opinion in Hematology 2001 8 3 131 136 2-s2.0-0035047271 10.1097/00062752-200105000-00001 (Pubitemid 32324632)
59. Forsey R. J., Thompson J. M., Ernerudh J., Hurst T. L., Strindhall J., Johansson B., Nilsson B.-O., Wikby A., Plasma cytokine profiles in elderly humans. Mechanisms of Ageing and Development 2003 124 4 487 493 2-s2.0-0037396220 10.1016/S0047-6374(03)00025-3 (Pubitemid 36514903)
60. Krabbe K. S., Pedersen M., Bruunsgaard H., Inflammatory mediators in the elderly. Experimental Gerontology 2004 39 5 687 699 2-s2.0-2342623445 10.1016/j.exger.2004.01.009 (Pubitemid 38586809)
61. Fulop T., Larbi A., Douziech N., Levesque I., Varin A., Herbein G., Cytokine receptor signalling and aging. Mechanisms of Ageing and Development 2006 127 6 526 537 2-s2.0-33646487013 10.1016/j.mad.2006.01.025
62. Gerli R., Monti D., Bistoni O., Mazzone A. M., Peri G., Cossarizza A., di Gioacchino M., Cesarotti M. E. F., Doni A., Mantovani A., Franceschi C., Paganelli R., Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mechanisms of Ageing and Development 2001 121 1-3 37 46 2-s2.0-0035915808 10.1016/S0047-6374(00)00195-0 (Pubitemid 32115398)
63. Myśliwska J., Bryl E., Foerster J., Myśliwski A., The upregulation of TNF α production is not a generalised phenomenon in the elderly between their sixth and seventh decades of life. Mechanisms of Ageing and Development 1999 107 1 1 14 2-s2.0-0040790480 10.1016/S0047-6374(98)00111-0 (Pubitemid 29113069)
64. Bruunsgaard H., Andersen-Ranberg K., Hjelmborg J. V. B., Pedersen B. K., Jeune B., Elevated levels of tumor necrosis factor alpha and mortality in centenarians. American Journal of Medicine 2003 115 4 278 283 2-s2.0-0041878545 10.1016/S0002-9343(03)00329-2 (Pubitemid 37088189)
65. Licastro F., Candore G., Lio D., Porcellini E., Colonna-Romano G., Franceschi C., Caruso C., Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immunity and Ageing 2005 2, article 8 2-s2.0-33845222777 10.1186/1742-4933-2-8 (Pubitemid 44848803)
66. Vasto S., Candore G., Balistreri C. R., Caruso M., Colonna-Romano G., Grimaldi M. P., Listi F., Nuzzo D., Lio D., Caruso C., Inflammatory networks in ageing, age-related diseases and longevity. Mechanisms of Ageing and Development 2007 128 1 83 91 2-s2.0-33846059036 10.1016/j.mad.2006.11.015 (Pubitemid 46073064)
67. Pawelec G., Larbi A., Derhovanessian E., Senescence of the human immune system. Journal of Comparative Pathology 2010 142 1 S39 S44 2-s2.0-73249125797 10.1016/j.jcpa.2009.09.005
68. Finnerty C. C., Jeschke M. G., Herndon D. N., Gamelli R., Gibran N., Klein M., Silver G., Arnoldo B., Remick D., Tompkins R. G., Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Molecular Medicine 2008 14 9-10 553 560 2-s2.0-55049092708 10.2119/2007-00132. Finnerty
69. Ahmed S. A., Hissong B. D., Verthelyi D., Donner K., Becker K., Karpuzoglu-Sahin E., Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environmental Health Perspectives 1999 107 supplement 5 681 686 2-s2.0-0010830725 (Pubitemid 29527770)
70. Hahn A. B., Kasten-Jolly J. C., Constantino D. M., Graffunder E., Singh T. P., Shen G. K., Conti D. J., TNF- α IL-6, IFN- γ and IL-10 gene expression polymorphisms and the IL-4 receptor α -chain variant Q576R: effects on renal allograft outcome. Transplantation 2001 72 4 660 665 2-s2.0-0035959294 (Pubitemid 32802749)
71. Eikelenboom M. J., Killestein J., Kragt J. J., Uitdehaag B. M. J., Polman C. H., Gender differences in multiple sclerosis: cytokines and vitamin D. Journal of the Neurological Sciences 2009 286 1-2 40 42 2-s2.0-70349777295 10.1016/j.jns.2009.06.025
72. Sadeghi M., Daniel V., Naujokat C., Wiesel M., Hergesell O., Opelz G., Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection. Transplant International 2005 18 2 177 185 2-s2.0-20444443541 10.1111/j.1432-2277.2005.00007.x (Pubitemid 41743308)
73. Pietschmann P., Gollob E., Brosch S., Hahn P., Kudlacek S., Willheim M., Woloszczuk W., Peterlik M., Tragl K. H., The effect of age and gender on cytokine production by human peripheral blood mononuclear cells and markers of bone metabolism. Experimental Gerontology 2003 38 10 1119 1127 2-s2.0-0142155094 10.1016/S0531-5565(03)00189-X (Pubitemid 37324423)
74. Petrovsky N., McNair P., Harrison L. C., Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine 1998 10 4 307 312 2-s2.0-0032055596 10.1006/cyto.1997. 0289 (Pubitemid 28227075)
75. Cutolo M., Seriolo B., Craviotto C., Pizzorni C., Sulli A., Circadian rhythms in RA. Annals of the Rheumatic Diseases 2003 62 7 593 596 2-s2.0-0038208315 10.1136/ard.62.7.593 (Pubitemid 36760552)
76. Cutolo M., Straub R. H., Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. Autoimmunity Reviews 2008 7 3 223 228 2-s2.0-37649021327 10.1016/j.autrev.2007.11.019
77. Lissoni P., Rovelli F., Brivio F., Brivio O., Fumagalli L., Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humans. Natural Immunity 1998 16 1 1 5 2-s2.0-0031739212 10.1159/000069464 (Pubitemid 28499441)
78. Knudsen L. S., Christensen I. J., Lottenburger T., Svendsen M. N., Nielsen H. J., Nielsen L., Hørslev-Petersen K., Jensen J. E. B., Kollerup G., Johansen J. S., Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with Rheumatoid Arthritis. Biomarkers 2008 13 1 59 78 2-s2.0-38049187988 10.1080/13547500701615017
79. Arvidson N. G., Gudbjornsson B., Elfman L., Ryden A.-C., Totterman T. H., Hallgren R., Circadian rhythm of serum interleukin-6 in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 1994 53 8 521 524 2-s2.0-0028094880 (Pubitemid 24256982)
80. Straub R. H., Cutolo M., Circadian rhythms in Rheumatoid Arthritis: implications for pathophysiology and therapeutic management. Arthritis & Rheumatism 2007 56 2 399 408 2-s2.0-33847025269 10.1002/art.22368
81. Cutolo M., Villaggio B., Otsa K., Aakre O., Sulli A., Seriolo B., Altered circadian rhythms in Rheumatoid Arthritis patients play a role in the disease's symptoms. Autoimmunity Reviews 2005 4 8 497 502 2-s2.0-26244451354 10.1016/j.autrev.2005.04.019 (Pubitemid 41415759)
82. Crofford L. J., Kalogeras K. T., Mastorakos G., Magiakou M.-A., Wells J., Kanik K. S., Gold P. W., Chrousos G. P., Wilder R. L., Circadian relationships between interleukin (IL)-6 and hypothalamic- pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated Rheumatoid Arthritis. Journal of Clinical Endocrinology & Metabolism 1997 82 4 1279 1283 2-s2.0-0030936387 10.1210/jc.82.4.1279 (Pubitemid 27166676)
83. Dandona P., Weinstock R., Thusu K., Abdel-Rahman E., Aljada A., Wadden T., Tumor necrosis factor- α in sera of obese patients: fall with weight loss. Journal of Clinical Endocrinology & Metabolism 1998 83 8 2907 2910 2-s2.0-0031784544 10.1210/jc.83.8.2907 (Pubitemid 28493796)
84. Blackburn P., Després J.-P., Lamarche B., Tremblay A., Bergeron J., Lemieux I., Couillard C., Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity 2006 14 10 1747 1754 2-s2.0-33846821855 10.1038/oby.2006.201 (Pubitemid 46214797)
85. Payette C., Blackburn P., Lamarche B., Tremblay A., Bergeron J., Lemieux I., Després J.-P., Couillard C., Sex differences in postprandial plasma tumor necrosis factor- α interleukin-6, and C-reactive protein concentrations. Metabolism 2009 58 11 1593 1601 2-s2.0-70449700189 10.1016/j.metabol.2009.05.011
86. Saah A. J., Hoover D. R., 'Sensitivity" and "specificity" reconsidered: the meaning of these terms in analytical and diagnostic settings. Annals of Internal Medicine 1997 126 1 91 94 2-s2.0-0031024931 (Pubitemid 27021232)
87. Tietz N. W., Burtis C. A., Ashwood E. R., Tietz Textbook of Clinical Chemistry 1994 WB Saunders
88. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., Quagliaro L., Ceriello A., Giugliano D., Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002 106 16 2067 2072 2-s2.0-0037109184 10.1161/01.CIR.0000034509.14906.AE (Pubitemid 35192812)
89. Carroll M. F., Schade D. S., Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers. Circulation 2003 108 1 24 31 2-s2.0-0038164595 10.1161/01.CIR.0000074221.68903.77 (Pubitemid 36859015)
90. Zhou X., Fragala M. S., McElhaney J. E., Kuchel G. A., Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Current Opinion in Clinical Nutrition and Metabolic Care 2010 13 5 541 547 2-s2.0-77955924626 10.1097/MCO.0b013e32833cf3bc
91. Grimble R. F., Nutritional modulation of cytokine biology. Nutrition 1998 14 7-8 634 640 2-s2.0-0031814522 10.1016/S0899-9007(98)00010-0 (Pubitemid 28345463)
92. Rowbottom D. G., Green K. J., Acute exercise effects on the immune system. Medicine and Science in Sports & Exercise 2000 32 7 S396 S405 2-s2.0-0033913159 (Pubitemid 30482639)
93. Ostrowski K., Rohde T., Zacho M., Asp S., Pedersen B. K., Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. Journal of Physiology 1998 508 3 949 953 2-s2.0-0031895668 10.1111/j.1469-7793. 1998.949bp.x (Pubitemid 28220743)
94. Steensberg A., Keller C., Starkie R. L., Osada T., Febbraio M. A., Pedersen B. K., IL-6 and TNF- α expression in, and release from, contracting human skeletal muscle. American Journal of Physiology 2002 283 6 E1272 E1278 2-s2.0-0036889057 (Pubitemid 35340635)
95. Gabriel H., Kindermann W., The acute immune response to exercise: what does it mean? International Journal of Sports Medicine 1997 18 1 S28 S45 2-s2.0-0030808273
96. Nieman D. C., Pedersen B. K., Exercise and immune function. Recent developments. Sports Medicine 1999 27 2 73 80 2-s2.0-0032977230 10.2165/00007256-199927020-00001 (Pubitemid 29123579)
97. Pedersen B. K., Steensberg A., Fischer C., Keller C., Keller P., Plomgaard P., Wolsk-Petersen E., Febbraio M., The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor? Proceedings of the Nutrition Society 2004 63 2 263 267 2-s2.0-2942702298 10.1079/PNS2004338 (Pubitemid 38787476)
98. Febbraio M. A., Pedersen B. K., Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. The FASEB Journal 2002 16 11 1335 1347 2-s2.0-0036720342 10.1096/fj.01-0876rev (Pubitemid 34913306)
99. Penkowa M., Keller C., Keller P., Jauffred S., Pedersen B. K., Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise. The FASEB Journal 2003 17 14 2166 2168 2-s2.0-0642364997
100. Baslund B., Lyngberg K., Andersen V., Kristensen J. H., Hansen M., Klokker M., Pedersen B. K., Effect of 8 wk of bicycle training on the immune system of patients with Rheumatoid Arthritis. Journal of Applied Physiology 1993 75 4 1691 1695 2-s2.0-0027525559 (Pubitemid 23318219)
101. Walsh N. P., Gleeson M., Shephard R. J., Gleeson M., Woods J. A., Bishop N. C., Fleshner M., Green C., Pedersen B. K., Hoffman-Goetz L., Rogers C. J., Northoff H., Abbasi A., Simon P., Position statement. Part one: immune function and exercise. Exercise Immunology Review 2011 17 1 6 63
102. Vgontzas A. N., Zoumakis E., Bixler E. O., Lin H.-M., Follett H., Kales A., Chrousos G. P., Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. Journal of Clinical Endocrinology & Metabolism 2004 89 5 2119 2126 2-s2.0-2442516101 10.1210/jc.2003-031562 (Pubitemid 38619840)
103. Barratt R. A., Bowens S. L., McCune S. K., Johannessen J. N., Buckman S. Y., The critical path initiative: leveraging collaborations to enhance regulatory science. Clinical Pharmacology and Therapeutics 2012 91 3 380 383 2-s2.0-84857197691 10.1038/clpt.2011.318
104. Lekander M., Elofsson S., Neve I.-M., Hansson L.-O., Unden A.-L., Self-rated health is related to levels of circulating cytokines. Psychosomatic Medicine 2004 66 4 559 563 2-s2.0-3242776858 10.1097/01.psy.0000130491.95823.94 (Pubitemid 38971251)
105. de Groote D., Zangerle P. F., Gevaert Y., Fassotte M. F., Beguin Y., Noizat-Pirenne F., Pirenne J., Gathy R., Lopez M., Dehart I., Igot D., Baudrihaye M., Delacroix D., Franchimont P., Direct stimulation of cytokines (IL-1 β TNF- α IL-6, IL-2, IFN- γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992 4 3 239 248 2-s2.0-0026858708
106. Peakman T. C., Elliott P., The UK Biobank sample handling and storage validation studies. International Journal of Epidemiology 2008 37 supplement 1 i2 i6 2-s2.0-41849087888 10.1093/ije/dyn019
107. Bienvenu J. A. D., Monneret G., Gutowski M. C., Fabien N., Cytokine assays in human sera and tissues. Toxicology 1998 129 1 55 61 2-s2.0-0032457184 10.1016/S0300-483X(98)00063-8 (Pubitemid 29084431)
108. Barelli S., Crettaz D., Thadikkaran L., Rubin O., Tissot J.-D., Plasma/serum proteomics: pre-analytical issues. Expert Review of Proteomics 2007 4 3 363 370 2-s2.0-34249998316 10.1586/14789450.4.3.363 (Pubitemid 46890073)
109. Hosnijeh F. S., Krop E. J. M., Portengen L., Rabkin C. S., Linseisen J., Vineis P., Vermeulen R., Stability and reproducibility of simultaneously detected plasma and serum cytokine levels in asymptomatic subjects. Biomarkers 2010 15 2 140 148 2-s2.0-77249117338 10.3109/13547500903340570
110. Cannon J. G., van der Meer J. W. M., Kwiatkowski D., Endres S., Lonnemann G., Burke J. F., Dinarello C. A., Interleukin-1 β in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods. Lymphokine Research 1988 7 4 457 467 2-s2.0-0024255853 (Pubitemid 19003312)
111. Whiteside T. L., Cytokines and cytokine measurements in a clinical laboratory. Clinical and Diagnostic Laboratory Immunology 1994 1 3 257 260 2-s2.0-0028427902 (Pubitemid 2085394)
112. Hoffmann J. N., Hartl W. H., Faist E., Jochum M., Inthorn D., Tumor necrosis factor measurement and use of different anticoagulants: possible interference in plasma samples and supernatants from endotoxin-stimulated monocytes. Inflammation Research 1997 46 9 342 347 2-s2.0-0030843261 10.1007/s000110050199 (Pubitemid 27443306)
113. Aziz N., Irwin M. R., Dickerson S. S., Butch A. W., Spurious tumor necrosis factor- α and interleukin-6 production by human monocytes from blood collected in endotoxin-contaminated vacutainer blood collection tubes. Clinical Chemistry 2004 50 11 2215 2216 2-s2.0-7044263129 10.1373/clinchem.2004. 040162 (Pubitemid 39425878)
114. Deeks J. J., Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. British Medical Journal 2001 323 7305 157 162 2-s2.0-0035928514 (Pubitemid 32678396)
115. Gilbertson-White S., Aouizerat B. E., Miaskowski C., Methodologic issues in the measurement of cytokines to elucidate the biological basis for cancer symptoms. Biological Research for Nursing 2011 13 1 15 24 2-s2.0-78650777670 10.1177/1099800410379497
116. Tworoger S. S., Hankinson S. E., Collection, processing, and storage of biological samples in epidemiologic studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples. Cancer Epidemiology Biomarkers & Prevention 2006 15 9 1578 1581 2-s2.0-33749326437 10.1158/1055-9965.EPI- 06-0629 (Pubitemid 44497089)
117. Czlonkowska A., Ciesielska A., Gromadzka G., Kurkowska-Jastrzebska I., Estrogen and cytokines production-the possible cause of gender differences in neurological diseases. Current Pharmaceutical Design 2005 11 8 1017 1030 2-s2.0-14744288140 10.2174/1381612053381693 (Pubitemid 40331302)
118. Haab B. B., Geierstanger B. H., Michailidis G., Vitzthum F., Forrester S., Okon R., Saviranta P., Brinker A., Sorette M., Perlee L., Suresh S., Drwal C., Adkins J. N., Omenn G. S., Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics 2005 5 13 3278 3291 2-s2.0-23944472689 10.1002/pmic.200401276 (Pubitemid 41192035)
119. Bowen R. A. R., Chan Y., Cohen J., Rehak N. N., Hortin G. L., Csako G., Remaley A. T., Effect of blood collection tubes on total triiodothyronine and other laboratory assays. Clinical Chemistry 2005 51 2 424 433 2-s2.0-12944293053 10.1373/clinchem.2004.043349 (Pubitemid 40175814)
120. Zhao X., Qureshi F., Eastman P. S., Manning W. C., Alexander C., Robinson W. H., Hesterberg L. K., Pre-analytical effects of blood sampling and handling in quantitative immunoassays for Rheumatoid Arthritis. Journal of Immunological Methods 2012 378 1-2 72 80 2-s2.0-84859434246 10.1016/j.jim.2012.02.007
121. Panicker G., Meadows K. S., Lee D. R., Nisenbaum R., Unger E. R., Effect of storage temperatures on the stability of cytokines in cervical mucous. Cytokine 2007 37 2 176 179 2-s2.0-34247856013 10.1016/j.cyto.2007.03.006 (Pubitemid 46694341)
122. de Jager W., Bourcier K., Rijkers G. T., Prakken B. J., Seyfert-Margolis V., Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunology 2009 10, article 52 2-s2.0-70449366867 10.1186/1471-2172-10-52
123. van der Linden M. W., Huizinga T. W. J., Stoeken D.-J., Sturk A., Westendorp R. G. J., Determination of tumour necrosis factor- α and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation. Journal of Immunological Methods 1998 218 1-2 63 71 2-s2.0-0032170346 10.1016/S0022-1759(98)00108-2 (Pubitemid 28500133)
124. Ray C. A., Dumaual C., Willey M., Fill J., O'Brien P. J., Gourley I., Devanarayan V., Konrad R. J., Optimization of analytical and pre-analytical variables associated with an ex vivo cytokine secretion assay. Journal of Pharmaceutical and Biomedical Analysis 2006 41 1 189 195 2-s2.0-33645093694 10.1016/j.jpba.2005.10.013
125. Leroux-Roels G., Offner F., Philippe J., Vermeulen A., Influence of blood-collecting systems on concentrations of tumor necrosis factor in serum and plasma. Clinical Chemistry 1988 34 11 2373 2374 2-s2.0-0024237753 (Pubitemid 19001283)
126. Thorpe R., Wadhwa M., Bird C. R., Mire-Sluis A. R., Detection and measurement of cytokines. Blood Reviews 1992 6 3 133 148 2-s2.0-0026688615 10.1016/0268-960X(92)90025-L
127. Lin F.-C., Cohen R., Losada R., Bush V., Cellular sedimentation and barrier formation under centrifugal force in blood collection tubes. Laboratory Medicine 2001 32 10 588 594 2-s2.0-0034784559 10.1309/H76B-JF9P-RGFU-9XD6 (Pubitemid 32946173)
128. Aziz N., Nishanian P., Taylor J. M. G., Mitsuyasu R. T., Jacobson J. M., Dezube B. J., Lederman M. M., Detels R., Fahey J. L., Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection. Journal of Infectious Diseases 1999 179 4 843 848 2-s2.0-0032900581 10.1086/314673 (Pubitemid 29159329)
129. Rai A. J., Vitzthum F., Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics. Expert Review of Proteomics 2006 3 4 409 426 2-s2.0-33747202452 10.1586/14789450.3.4.409 (Pubitemid 44231984)
130. Mire-Sluis A. R., Padilla A., Das R. G., Biological standardization of cytokines and growth factors. Developments in Biological Standardization 1999 97 171 176 2-s2.0-0032605377
131. Sachdeva N., Asthana D., Cytokine quantitation: technologies and applications. Frontiers in Bioscience 2007 12 12 4682 4695 2-s2.0-34347225102 10.2741/2418
132. Aukrust P., Müller F., Lien E., Nordøy I., Liabakk N.-B., Kvale D., Espevik T., Frøland S. S., Tumor Necrosis Factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. Journal of Infectious Diseases 1999 179 1 74 82 2-s2.0-0032928963 10.1086/314572 (Pubitemid 29028341)
133. Aukrust P., Frøland S. S., Liabakk N.-B., Müller F., Nordøy I., Haug C., Espevik T., Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood 1994 84 7 2136 2143 2-s2.0-0028024881 (Pubitemid 24296369)
134. Engelberts I., Stephens S., Francot G. J. M., van der Linden C. J., Buurman W. A., Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. The Lancet 1991 338 8765 515 516 2-s2.0-0025740571
135. Toedter G., Hayden K., Wagner C., Brodmerkel C., Simultaneous detection of eight analytes in human serum by two commercially available platforms for multiplex cytokine analysis. Clinical and Vaccine Immunology 2008 15 1 42 48 2-s2.0-43149108869 10.1128/CVI.00211-07 (Pubitemid 351966532)
136. Chau C. H., Rixe O., McLeod H., Figg W. D., Validation of analytic methods for biomarkers used in drug development. Clinical Cancer Research 2008 14 19 5967 5976 2-s2.0-58149154725 10.1158/1078-0432.CCR-07-4535
137. Morgan E., Varro R., Sepulveda H., Ember J. A., Apgar J., Wilson J., Lowe L., Chen R., Shivraj L., Agadir A., Campos R., Ernst D., Gaur A., Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clinical Immunology 2004 110 3 252 266 2-s2.0-12144290406 10.1016/j.clim.2003.11.017 (Pubitemid 38402005)
138. Dabitao D., Margolick J. B., Lopez J., Bream J. H., Multiplex measurement of proinflammatory cytokines in human serum: comparison of the Meso Scale Discovery electrochemiluminescence assay and the Cytometric Bead Array. Journal of Immunological Methods 2011 372 1-2 71 77 2-s2.0-80052495503 10.1016/j.jim.2011.06.033
139. Roux-Lombard P., Steiner G., Dayer J.-M., d'Angeac A. D., Emery P., Gordon C., Gallati H., Hasler F., Villiger P., Maini R. N., Cope A., Smolen J. S., van de Putte L. B. A., van de Loo F. A. J., Veys E. M., Malfait A. M., Vischer T., Guerne P., Preliminary report on cytokine determination in human synovial fluids: a consensus study of the European Workshop for Rheumatology Research. Clinical and Experimental Rheumatology 1992 10 5 515 520 2-s2.0-0026658397
140. Bienvenu J., Monneret G., Fabien N., Revillard J. P., The clinical usefulness of the measurement of cytokines. Clinical Chemistry and Laboratory Medicine 2000 38 4 267 285 2-s2.0-0033921030 (Pubitemid 30444953)
141. Madry N., Auerbach B., Schelp C., Measures to overcome HAMA interferences in immunoassays. Anticancer Research 1997 17 4 2883 2886 2-s2.0-0030841625 (Pubitemid 27434811)
142. Dimeski G., Interference testing. The Clinical Biochemist Reviews 2008 29 supplement 1 S43 S48
143. Wadhwa M., Seghatchian M. J., Dilger P., Sands D., Krailadisiri P., Contreras M., Thorpe R., Cytokines in WBC-reduced apheresis pcs during storage: a comparison of two WBC-reduction methods. Transfusion 2000 40 9 1118 1126 2-s2.0-0033818711 10.1046/j.1537-2995.2000.40091118.x
144. Svenson M., Hansen M. B., Kayser L., Rasmussen Å. K., Reimert C. M., Bendtzen K., Effects of human anti-IL-1 α autoantibodies on receptor binding and biological activities of IL-1. Cytokine 1992 4 2 125 133 2-s2.0-0026828978
145. Hansen M. B., Svenson M., Abell K., Varming K., Nielsen H. P., Bertelsen A., Bendtzen K., Sex- and age-dependency of IgG auto-antibodies against IL-1 α in healthy humans. European Journal of Clinical Investigation 1994 24 3 212 218 2-s2.0-0028235934 (Pubitemid 24197271)
146. Bendtzen K., Hansen M. B., Diamant M., Ross C., Svenson M., Naturally occurring autoantibodies to interleukin-1 α interleukin-6, interleukin-10, and interferon- α Journal of Interferon Research 1994 14 4 157 158 2-s2.0-0028068397 (Pubitemid 24292461)
147. Revoltella R. P., Natural and therapeutically-induced antibodies to cytokines. Biotherapy 1998 10 4 321 331 2-s2.0-0031920770 (Pubitemid 28201955)
148. Hansen M. B., Andersen V., Rohde K., Florescu A., Ross C., Svenson M., Bendtzen K., Cytokine autoantibodies in Rheumatoid Arthritis. Scandinavian Journal of Rheumatology 1995 24 4 197 203 2-s2.0-0029135388
149. Chapman K., The ProteinChip Biomarker System from Ciphergen Biosystems: a novel proteomics platform for rapid biomarker discovery and validation. Biochemical Society Transactions 2002 30 2 82 87 2-s2.0-0036549707
150. Preissner C. M., Dodge L. A., O'Kane D. J., Singh R. J., Grebe S. K. G., Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays. Clinical Chemistry 2005 51 1 208 210 2-s2.0-11144270161 10.1373/clinchem.2004.040501 (Pubitemid 40024033)
151. Bonetti A., Monica C., Bonaguri C., Gnocchi C., Russo A., Battistelli L., Musiari L., Pastori P., Novarini A., Interference by heterophilic antibodies in immunoassays: wrong increase of myoglobin values. Acta Biomedica de l'Ateneo Parmense 2008 79 2 140 143 2-s2.0-55249120186
152. Levinson S. S., Miller J. J., Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clinica Chimica Acta 2002 325 1-2 1 15 2-s2.0-0036844469 10.1016/S0009-8981(02) 00275-9 (Pubitemid 35279621)
153. Bolstad N., Warren D. J., Bjerner J., Kravdal G., Schwettmann L., Olsen K. H., Rustad P., Nustad K., Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera. Clinical Chemistry and Laboratory Medicine 2012 49 12 2001 2006 10.1515/CCLM.2011.702
154. Muller W., Mierau R., Wohltmann D., Interference of IgM rheumatoid factor with nephelometric C-reactive protein determinations. Journal of Immunological Methods 1985 80 1 77 90 2-s2.0-0021869027 10.1016/0022-1759(85)90166-8 (Pubitemid 15054567)
155. Raza K., Falciani F., Curnow S. J., Ross E. J., Lee C.-Y., Akbar A. N., Lord J. M., Gordon C., Buckley C. D., Salmon M., Early Rheumatoid Arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Research & Therapy 2005 7 4 R784 R795 2-s2.0-21644479222
156. Vaidya H. C., Beatty B. G., Eliminating interference from heterophilic antibodies in a two-site immunoassay for creatine kinase MB by using F(ab′)2 conjugate and polyclonal mouse IgG. Clinical Chemistry 1992 38 9 1737 1742 2-s2.0-0026702425
157. Todd D. J., Knowlton N., Amato M., Frank M. B., Schur P. H., Izmailova E. S., Roubenoff R., Shadick N. A., Weinblatt M. E., Centola M., Lee D. M., Erroneous augmentation of multiplex assay measurements in patients with Rheumatoid Arthritis due to heterophilic binding by serum rheumatoid factor. Arthritis & Rheumatism 2011 63 4 894 903 2-s2.0-79953676591 10.1002/art.30213
158. Chandra P. E., Sokolove J., Hipp B. G., Lindstrom T. M., Elder J. T., Reveille J. D., Eberl H., Klause U., Robinson W. H., Novel multiplex technology for diagnostic characterization of Rheumatoid Arthritis. Arthritis Research & Therapy 2011 13 3, article R102 2-s2.0-79959472516 10.1186/ar3383
159. Ledur A., Fitting C., David B., Hamberger C., Cavaillon J.-M., Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards. Journal of Immunological Methods 1995 186 2 171 179 2-s2.0-0028785996 10.1016/0022-1759(95)00184-C
160. Mire-Sluis A. R., Das R. G., Thorpe R., The international standard for Granulocyte Colony Stimulating Factor (G-CSF). Evaluation in an international collaborative study. Journal of Immunological Methods 1995 179 1 117 126 2-s2.0-0028854947 10.1016/0022-1759(94)00272-X
161. Mire-Sluis A. R., Das R. G., Thorpe R., The international standard for Macrophage Colony Stimulating Factor (M-CSF). Evaluation in an international collaborative study. Journal of Immunological Methods 1995 179 2 141 151 2-s2.0-0028900729 10.1016/0022-1759(94)00306-H
162. Das R. E. G., Poole S., The international standard for interleukin-6. Evaluation in an international collaborative study. Journal of Immunological Methods 1993 160 2 147 153 2-s2.0-0027418962 10.1016/0022-1759(93)90172-4
163. Mire-Sluis A. R., Das R. G., Thorpe R., Implications for the assay and biological activity of interleukin-4: results of a WHO international collaborative study. Journal of Immunological Methods 1996 194 1 13 25 10.1016/0022-1759(96)00069-5 (Pubitemid 26291191)
164. Mire-Sluis A. R., Das R. G., Thorpe R., Implications for the assay and biological activity of interleukin-8: results of a WHO international collaborative study. Journal of Immunological Methods 1997 200 1-2 1 16 2-s2.0-0342981754 10.1016/S0022-1759(96)00157-3 (Pubitemid 27035682)
165. Mire-Sluis A. R., Gaines-Das R., Thorpe R., Immunoassays for detecting cytokines: what are they really measuring? Journal of Immunological Methods 1995 186 2 157 160 2-s2.0-0028784931 10.1016/0022-1759(95)00128-W
166. Poole S., Das R. E. G., The international standards for interleukin-1 α and interleukin-1 β. Evaluation in an international collaborative study. Journal of Immunological Methods 1991 142 1 1 13 2-s2.0-0025863855 10.1016/0022-1759(91)90286-O
167. Romagnani S., del Prete G., Manetti R., Ravina A., Annunziato F., de Carli M., Mazzetti M., Piccinni M.-P., D'Elios M. M., Parronchi P., Sampognaro S., Maggi E., Role of TH1/TH2 cytokines in HIV infection. Immunological Reviews 1994 140 73 92 2-s2.0-0028168942
168. Aziz N., Nishanian P., Fahey J. L., Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clinical and Diagnostic Laboratory Immunology 1998 5 6 755 761 2-s2.0-0031773989 (Pubitemid 28519247)
169. Meager A., Measurement of cytokines by bioassays: theory and application. Methods 2006 38 4 237 252 2-s2.0-33644943959 10.1016/j.ymeth.2005.11.005
170. House R. V., Cytokine measurement techniques for assessing hypersensitivity. Toxicology 2001 158 1-2 51 58 2-s2.0-0035793385 10.1016/S0300-483X(00)00401-7 (Pubitemid 32119496)
171. Miller K. J., Bowsher R. R., Celniker A., Gibbons J., Gupta S., Lee J. W., Swanson S. J., Smith W. C., Weiner R. S., Crommelin D. J. A., Das I., DeSilva B. S., Dillard R. F., Geier M., Gunn H., Khan M. N., Knuth D. W., Kunitani M., Nordblom G. D., Paulussen R. J. A., Sailstad J. M., Tacey R. L., Watson A., Workshop on bioanalytical methods validation for macromolecules: summary report. Pharmaceutical Research 2001 18 9 1373 1383 2-s2.0-0034852176 10.1023/A:1013062600566 (Pubitemid 32846335)
172. Lee J. W., Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics. Bioanalysis 2009 1 8 1461 1474 2-s2.0-79953008926
173. Smolec J., DeSilva B., Smith W., Weiner R., Kelly M., Lee B., Khan M., Tacey R., Hill H., Celniker A., Shah V., Bowsher R., Mire-Sluis A., Findlay J. W. A., Saltarelli M., Quarmby V., Lansky D., Dillard R., Ullmann M., Keller S., Karnes H. T., Bioanalytical method validation for macromolecules in support of pharmacokinetic studies. Pharmaceutical Research 2005 22 9 1425 1431 2-s2.0-24044467097 10.1007/s11095-005-5917-9 (Pubitemid 41215881)
174. Hetland M. L., Christensen I. J., Lottenburger T., Johansen J. S., Svendsen M. N., Hørslev-Petersen K., Nielsen L., Jørgen Nielsen H., Circulating VEGF as a biological marker in patients with Rheumatoid Arthritis? Preanalytical and biological variability in healthy persons and in patients. Disease Markers 2008 24 1 1 10 2-s2.0-36448967835 (Pubitemid 350174565)
175. Chabaud M., Fossiez F., Taupin J.-L., Miossec P., Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by Rheumatoid Arthritis synoviocytes and its regulation by Th2 cytokines. Journal of Immunology 1998 161 1 409 414 2-s2.0-0031802932 (Pubitemid 28285549)
176. Miossec P., Anti-inflammatory properties of interleukin-4. Revue du Rhumatisme 1993 60 2 87 91 2-s2.0-0027225408
177. Ponchel F., Verburg R. J., Bingham S. J., IL-7 deficiency and therapy-induced lymphopenia in Rheumatoid Arthritis. Arthritis Research & Therapy 2005 7 1 R82 R92 10.1186/ar1452
178. Churchman S. M., Ponchel F., Interleukin-7 in Rheumatoid Arthritis. Rheumatology 2008 47 6 753 759 2-s2.0-44849125718 10.1093/rheumatology/ken053 (Pubitemid 351796357)
179. Goëb V., Aegerter P., Parmar R., Fardellone P., Vittecoq O., Conaghan P. G., Emery P., le Loët X., Ponchel F., Progression to Rheumatoid Arthritis in early inflammatory arthritis is associated with low IL-7 serum levels. Annals of the Rheumatic Diseases 2013 72 6 1032 1036 10.1136/annrheumdis-2012-202377
180. Faucher S., Crawley A. M., Decker W., Sherring A., Bogdanovic D., Ding T., Bergeron M., Angel J. B., Sandstrom P., Development of a quantitative bead capture assay for soluble IL-7 receptor alpha in human plasma. PLoS ONE 2009 4 8 2-s2.0-68949207154 10.1371/journal.pone.0006690 e6690
181. Badot V., Durez P., van den Eynde B. J., Nzeusseu-Toukap A., Houssiau F. A., Lauwerys B. R., Rheumatoid Arthritis synovial fibroblasts produce a soluble form of the interleukin-7 receptor in response to pro-inflammatory cytokines. Journal of Cellular and Molecular Medicine 2011 15 11 2335 2342 2-s2.0-79960173004 10.1111/j.1582-4934.2010.01228.x
182. Scheller J., Rose-John S., Interleukin-6 and its receptor: from bench to bedside. Medical Microbiology and Immunology 2006 195 4 173 183 2-s2.0-33750166463 10.1007/s00430-006-0019-9 (Pubitemid 44600378)
183. Fabre S., Guisset C., Tatem L., Dossat N., Dupuy A. M., Cohen J. D., Cristol J. P., Daures J. P., Jorgensen C., Protein biochip array technology to monitor rituximab in Rheumatoid Arthritis. Clinical and Experimental Immunology 2009 155 3 395 402 2-s2.0-59249101969 10.1111/j.1365-2249.2008.03804.x
184. Maurice M. M., Nakamura H., van der Voort E. A. M., van Vliet A. I., Staal F. J. T., Tak P.-P., Breedveld F. C., Verweij C. L., Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in Rheumatoid Arthritis. Journal of Immunology 1997 158 3 1458 1465 2-s2.0-0031065210 (Pubitemid 127469974)
185. Cope A. P., Liblau R. S., Yang X.-D., Congia M., Laudanna C., Schreiber R. D., Probert L., Kollias G., McDevitt H. O., Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. Journal of Experimental Medicine 1997 185 9 1573 1584 2-s2.0-0030911341 10.1084/jem.185.9.1573 (Pubitemid 27203254)
186. Remans P. H. J., Gringhuis S. I., van Laar J. M., Sanders M. E., Papendrecht-van der Voort E. A. M., Zwartkruis F. J. T., Levarht E. W. N., Rosas M., Coffer P. J., Breedveld F. C., Bos J. L., Tak P. P., Verweij C. L., Reedquist K. A., Rap1 signaling is required for suppression of Ras-generated reactive oxygen species and protection against oxidative stress in T lymphocytes. Journal of Immunology 2004 173 2 920 931 2-s2.0-3142688998 (Pubitemid 38924265)
187. Remans P. H. J., Wijbrandts C. A., Sanders M. E., Toes R. E., Breedveld F. C., Tak P. P., van Laar J. M., Reedquist K. A., CTLA-4Ig suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPase mediator of oxidative stress in Rheumatoid Arthritis T cells. Arthritis & Rheumatism 2006 54 10 3135 3143 2-s2.0-33750343810 10.1002/art.22139 (Pubitemid 44622084)
188. Abreu J. R. F., Krausz S., Dontje W., Grabiec A. M., de Launay D., Nolte M. A., Tak P. P., Reedquist K. A., Sustained T cell Rap1 signaling is protective in the collagen-induced arthritis model of Rheumatoid Arthritis. Arthritis & Rheumatism 2010 62 11 3289 3299 2-s2.0-78249242763 10.1002/art.27656
189. Ponchel F., Morgan A. W., Bingham S. J., Quinn M., Buch M., Verburg R. J., Henwood J., Douglas S. H., Masurel A., Conaghan P., Gesinde M., Taylor J., Markham A. F., Emery P., van Laar J. M., Isaacs J. D., Dysregulated lymphocyte proliferation and differentiation in patients with Rheumatoid Arthritis. Blood 2002 100 13 4550 4556 2-s2.0-0037114690 10.1182/blood-2002-03-0671 (Pubitemid 35429697)
190. Unutmaz D., Pileri P., Abrignani S., Antigen-independent activation of naive and memory resting T cells by a cytokine combination. Journal of Experimental Medicine 1994 180 3 1159 1164 2-s2.0-0027935476 10.1084/jem.180.3.1159 (Pubitemid 24256630)
191. Unutmaz D., Baldoni F., Abrignani S., Human naive T cells activated by cytokines differentiate into a split phenotype with functional features intermediate between naive and memory T cells. International Immunology 1995 7 9 1417 1424 2-s2.0-0029095086
192. Brennan F. M., Hayes A. L., Ciesielski C. J., Green P., Foxwell B. M., Feldmann M., Evidence that Rheumatoid Arthritis synovial T cells are similar to cytokine-activated T cells-involvement of phosphatidylinositol 3-kinase and nuclear factor kappa B pathways in tumor necrosis factor a production in Rheumatoid Arthritis. Arthritis & Rheumatism 2002 46 1 31 41 (Pubitemid 34121648)
193. Beech J. T., Andreakos E., Ciesielski C. J., Green P., Foxwell B. M. J., Brennan F. M., T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NF B: implications for Rheumatoid Arthritis. Arthritis Research & Therapy 2006 8 6, article R168 2-s2.0-35148817450 10.1186/ar2077
194. Altomonte L., Zoli A., Mirone L., Scolieri P., Magaro M., Serum levels of interleukin-1b, tumour necrosis factor-a and interleukin-2 in Rheumatoid Arthritis. Correlation with disease activity. Clinical Rheumatology 1992 11 2 202 205 2-s2.0-0026658935 10.1007/BF02207957
195. Burgoyne C. H., Field S. L., Brown A. K., Hensor E. M., English A., Bingham S. L., Verburg R., Fearon U., Lawson C. A., Hamlin P. J., Straszynski L., Veale D., Conaghan P., Hull M. A., van Laar J. M., Tennant A., Emery P., Isaacs J. D., Ponchel F., Abnormal T-cell differentiation persists in Rheumatoid Arthritis patients in clinical remission and predicts relapse. Annals of the Rheumatic Diseases 2008 67 6 750 757 10.1136/ard.2007.073833 (Pubitemid 351829373)
196. Churchman S. M., Ponchel F., Interleukin-7 in Rheumatoid Arthritis. Rheumatology 2008 47 6 753 759 2-s2.0-44849125718 10.1093/rheumatology/ken053 (Pubitemid 351796357)
197. Harada S., Yamamura M., Okamoto H., Morita Y., Kawashima M., Aita T., Makino H., Production of interleukin-7 and interleukin-15 by fibroblast- like synoviocytes from patients with Rheumatoid Arthritis. Arthritis & Rheumatism 1999 42 7 1508 1516 (Pubitemid 30265610)
198. Blaschke S., Schulz H., Schwarz G., Blaschke V., Müller G. A., Reuss-Borst M., Interleukin 16 expression in relation to disease activity in Rheumatoid Arthritis. Journal of Rheumatology 2001 28 1 12 21 2-s2.0-0035166936 (Pubitemid 32062019)
199. Amital H., Barak V., Winkler R. E., Rubinow A., Impact of treatment with infliximab on serum cytokine profile of patients with rheumatoid and psoriatic arthritis. Annals of the New York Academy of Sciences 2007 1110 1 649 660 2-s2.0-35748951619 10.1196/annals.1423.068 (Pubitemid 350043054)
200. Joosten L. A. B., Radstake T. R. D., Lubberts E., van den Bersselaar L. A. M., van Riel P. L. C. M., van Lent P. L. E. M., Barrera P., van den Berg W. B., Association of interleukin-18 expression with enhanced levels of both interleukin-1 β and tumor necrosis factor α in knee synovial tissue of patients with Rheumatoid Arthritis. Arthritis & Rheumatism 2003 48 2 339 347 2-s2.0-0037331297 10.1002/art.10814 (Pubitemid 36278001)
201. Gouda E. A., Aboulata A. A., Elharoun A. S., Tawfik A. H., Hossney A., Reda A. M., Desoky K. M., Interleukin-18 expression in rheumatoid artheritis synovial tissue and its relation to disease activity. The Egyptian Journal of Immunology 2007 14 2 1 10 2-s2.0-77951627448
202. Niu X., He D., Zhang X., Yue T., Li N., Zhang J. Z., Dong C., Chen G., IL-21 regulates Th17 cells in Rheumatoid Arthritis. Human Immunology 2010 71 4 334 341 2-s2.0-77950538932 10.1016/j.humimm.2010.01.010
203. Elkayam O., Yaron I., Shirazi I., Yaron M., Caspi D., Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatology International 2000 19 3 101 105 2-s2.0-0034077304 (Pubitemid 30189841)
204. Jacob S. E., Nassiri M., Kerdel F. A., Vincek V., Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Mediators of Inflammation 2003 12 5 309 313 2-s2.0-0242693481 10.1080/09629350310001619753 (Pubitemid 37392904)
205. Arican O., Aral M., Sasmaz S., Ciragil P., Serum levels of TNF- α IFN- γ IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators of Inflammation 2005 2005 5 273 279 2-s2.0-27644565806 10.1155/MI.2005.273 (Pubitemid 41577417)
206. Lourenço E. V., la Cava A., Cytokines in systemic lupus erythematosus. Current Molecular Medicine 2009 9 3 242 254 2-s2.0-65649148625 10.2174/156652409787847263
207. Lai K. N., Yap D. Y. H., Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. Journal of Biomedicine and Biotechnology 2010 2010 10 2-s2.0-77952540303 10.1155/2010/365083 365083
208. Vazquez-del Mercado M., Garcia-Gonzalez A., Muñoz-Valle J. F., Garcia-Iglesias T., Martinez-Bonilla G., Bernard-Medina G., Sanchez-Ortiz A., Ornelas-Aguirre J. M., Salazar-Paramo M., Gamez-Nava J. I., Gonzalez-Lopez L., Interleukin 1 β (IL-L β), IL-10, tumor necrosis factor- α and cellular proliferation index in peripheral blood mononuclear cells in patients with ankylosing spondylitis. Journal of Rheumatology 2002 29 3 522 526 2-s2.0-0036009101 (Pubitemid 34207681)
209. Gratacos J., Collado A., Filella X., Sanmarti R., Canete J., Llena J., Molina R., Ballesta A., Munoz-Gomez J., Serum cytokines (IL-6, TNF- α IL- β and IFN- γ) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. British Journal of Rheumatology 1994 33 10 927 931 2-s2.0-0027943397 (Pubitemid 24324807)
210. Bal A., Unlu E., Bahar G., Aydog E., Eksioglu E., Yorgancioglu R., Comparison of serum IL-1 β sIL-2R, IL-6, and TNF- α levels with disease activity parameters in ankylosing spondylitis. Clinical Rheumatology 2007 26 2 211 215 2-s2.0-33845875436 10.1007/s10067-006-0283-5 (Pubitemid 46020247)
211. Needleman B. W., Wigley F. M., Stair R. W., Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α and interferon- γ levels in sera from patients with scleroderma. Arthritis & Rheumatism 1992 35 1 67 72 2-s2.0-0026601232
212. Hasegawa M., Takehara K., Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines. Seminars in Arthritis and Rheumatism 2012 42 3 281 296 2-s2.0-84859931348 10.1016/j.semarthrit.2012.03.014
213. Jansen A. L. M. A., van der Horst-Bruinsma I. E., van Schaardenburg D., van de Stadt R. J., de Koning M. H. M. T., Dijkmans B. A. C., Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate Rheumatoid Arthritis from undifferentiated polyarthritis in patients with early arthritis. Journal of Rheumatology 2002 29 10 2074 2076 2-s2.0-0036791894
214. Goëb V., Jouen F., Gilbert D., le Loët X., Tron F., Vittecoq O., Diagnostic and prognostic usefulness of antibodies to citrullinated peptides. Joint Bone Spine 2009 76 4 343 349 2-s2.0-67649814646 10.1016/j.jbspin.2008.12.006
215. Barker P. E., Cancer biomarker validation: standards and process-roles for the National Institute of Standards and Technology (NIST). Annals of the New York Academy of Sciences 2003 983 142 150 2-s2.0-0037354520 (Pubitemid 36399327)
216. Cañete J. D., Llena J., Collado A., Sanmartí R., Gayá A., Gratacós J., Blay M., Muñoz-Gómez J., Comparative cytokine gene expression in synovial tissue of early Rheumatoid Arthritis and seronegative spondyloarthropathies. British Journal of Rheumatology 1997 36 1 38 42 2-s2.0-0343907263
217. Hoy M. D. S., Williams J. L., Kirkham B. W., Symmetrical synovial fluid cell cytokine messenger RNA expression in Rheumatoid Arthritis: analysis by reverse transcription/polymerase chain reaction. British Journal of Rheumatology 1997 36 2 170 173 2-s2.0-0030759748
218. Raza K., Falciani F., Curnow S. J., Ross E. J., Lee C.-Y., Akbar A. N., Lord J. M., Gordon C., Buckley C. D., Salmon M., Early Rheumatoid Arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Research & Therapy 2005 7 4 R784 R795 2-s2.0-21644479222
219. Kokkonen H., Söderström I., Rocklöv J., Hallmans G., Lejon K., Dahlqvist S. R., Up-regulation of cytokines and chemokines predates the onset of Rheumatoid Arthritis. Arthritis & Rheumatism 2010 62 2 383 391 2-s2.0-75749152060 10.1002/art.27186
220. Jørgensen K. T., Wiik A., Pedersen M., Hedegaard C. J., Vestergaard B. F., Gislefoss R. E., Kvien T. K., Wohlfahrt J., Bendtzen K., Frisch M., Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with Rheumatoid Arthritis: case-control study nested in a cohort of Norwegian blood donors. Annals of the Rheumatic Diseases 2008 67 6 860 866 2-s2.0-39749199890 10.1136/ard.2007.073825 (Pubitemid 351829389)
221. Fry T. J., Mackall C. L., Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends in Immunology 2001 22 10 564 571 2-s2.0-0035471754 10.1016/S1471-4906(01)02028-2 (Pubitemid 33016404)
222. Ponchel F., Cuthbert R. J., Goëb V., IL-7 and lymphopenia. Clinica Chimica Acta 2011 412 1-2 7 16 2-s2.0-78650514849 10.1016/j.cca.2010.09.002
223. Natsumeda M., Nishiya K., Ota Z., Stimulation by interleukin-7 of mononuclear cells in peripheral blood, synovial fluid and synovial tissue from patients with Rheumatoid Arthritis. Acta Medica Okayama 1993 47 6 391 397 2-s2.0-0027767295
224. + T cells and macrophages. Arthritis & Rheumatism 2005 52 6 1700 1710 2-s2.0-20744439542 10.1002/art.21045 (Pubitemid 40852878)
225. Makino T., Fukushima S., Wakasugi S., Ihn H., Decreased serum IL-7 levels in patients with systemic sclerosis. Clinical and Experimental Rheumatology 2009 27 3 S68 S69 2-s2.0-70350322330
226. Andreu-Ballester J. C., Pérez-Griera J., Garcia-Ballesteros C., Amigo V., Catalán-Serra I., Monforte-Albalat A., Bixquert-Jiménez M., Ballester F., Deficit of interleukin-7 in serum of patients with Crohn's disease. Inflammatory Bowel Diseases 2013 19 2 E30 E31 2-s2.0-84856567792 10.1002/ibd.22914
227. Kader H. A., Tchernev V. T., Satyaraj E., Lejnine S., Kotler G., Kingsmore S. F., Patel D. D., Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF- β 1 and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease. The American Journal of Gastroenterology 2005 100 2 414 423 2-s2.0-13944278508 10.1111/j.1572-0241.2005. 40819.x (Pubitemid 40314529)
228. Wright H. L., Bucknall R. C., Moots R. J., Edwards S. W., Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatology 2012 51 3 451 459 2-s2.0-84857612440 10.1093/rheumatology/ker338 ker338
229. Das S., Vital E. M., Horton S., Bryer D., El-Sherbiny Y., Rawstron A. C., Ponchel F., Emery P., Buch M. H., Abatacept or tocilizumab after rituximab in Rheumatoid Arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy. Annals of the Rheumatic Diseases 2014 10.1136/annrheumdis- 2013-204417
230. Wijbrandts C. A., Dijkgraaf M. G. W., Kraan M. C., Vinkenoog M., Smeets T. J., Dinant H., Vos K., Lems W. F., Wolbink G. J., Sijpkens D., Dijkmans B. A. C., Tak P. P., The clinical response to infliximab in Rheumatoid Arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium. Annals of the Rheumatic Diseases 2008 67 8 1139 1144 2-s2.0-47949100980 10.1136/ard.2007.080440
231. Lindberg J., af Klint E., Catrina A. I., Nilsson P., Klareskog L., Ulfgren A.-K., Lundeberg J., Effect of infliximab on mRNA expression profiles in synovial tissue of Rheumatoid Arthritis patients. Arthritis Research & Therapy 2006 8, article R179 2-s2.0-33846786707 10.1186/ar2090 (Pubitemid 46211012)
232. van der Pouw Kraan T. C. M., Wijbrandts C. A., van Baarsen L. G., Rustenburg F., Baggen J. M., Verweij C. L., Tak P. P., Responsiveness to anti-tumour necrosis factor α therapy is related to pre-treatment tissue inflammation levels in Rheumatoid Arthritis patients. Annals of the Rheumatic Diseases 2008 67 4 563 566 2-s2.0-41849115276 10.1136/ard.2007.081950 (Pubitemid 351498442)
233. Marotte H., Maslinski W., Miossec P., Circulating tumour necrosis factor-alpha bioactivity in Rheumatoid Arthritis patients treated with infliximab: link to clinical response. Arthritis Research & Therapy 2005 7 1 R149 R155 2-s2.0-24144462259
234. Koczan D., Drynda S., Hecker M., Drynda A., Guthke R., Kekow J., Thiesen H.-J., Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in Rheumatoid Arthritis by etanercept. Arthritis Research & Therapy 2008 10 3, article R50 2-s2.0-44449110026 10.1186/ar2419 (Pubitemid 351757110)
235. Häupl T., Stuhlmüller B., Grützkau A., Radbruch A., Burmester G.-R., Does gene expression analysis inform us in Rheumatoid Arthritis? Annals of the Rheumatic Diseases 2010 69 supplement 1 i37 i42 2-s2.0-75749109331 10.1136/ard.2009.119487
236. Stuhlmüller B., Häupl T., Tandon N., Microarray analysis for molecular characterization of disease activity and measuring outcomes of anti-tumour necrosis factor therapy in Rheumatoid Arthritis. Arthritis Research & Therapy 2005 7, article P159 10.1186/ar1680
237. Lequerré T., Gauthier-Jauneau A.-C., Bansard C., Gene profiling in white blood cells predicts infliximab responsiveness in Rheumatoid Arthritis. Arthritis Research & Therapy 2006 8 4, article R105 10.1186/ar1990
238. Julià A., Erra A., Palacio C., Tomas C., Sans X., Barceló P., Marsal S., An eight-gene blood expression profile predicts the response to infliximab in Rheumatoid Arthritis. PLoS ONE 2009 4 10 2-s2.0-70449571942 10.1371/journal.pone.0007556 e7556
239. Zivojinovic S. M., Pejnovic N. N., Sefik-Bukilica M. N., Kovacevic L. V., Soldatovic I. I., Damjanov N. S., Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in Rheumatoid Arthritis. Journal of Rheumatology 2012 39 1 18 21 2-s2.0-84855398109 10.3899/jrheum.110697
240. Thurlings R. M., Boumans M., Tekstra J., van Roon J. A., Vos K., van Westing D. M., van Baarsen L. G., Bos C., Kirou K. A., Gerlag D. M., Crow M. K., Bijlsma J. W., Verweij C. L., Tak P. P., Relationship between the type I interferon signature and the response to rituximab in Rheumatoid Arthritis patients. Arthritis & Rheumatism 2010 62 12 3607 3614 2-s2.0-78650063161 10.1002/art.27702
241. Vosslamber S., Raterman H. G., van der Pouw Kraan T. C. T. M., Schreurs M. W. J., von Blomberg B. M. E., Nurmohamed M. T., Lems W. F., Dijkmans B. A. C., Voskuyl A. E., Verweij C. L., Pharmacological induction of interferon type i activity following treatment with rituximab determines clinical response in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 2011 70 6 1153 1159 2-s2.0-79955823796 10.1136/ard.2010.147199
242. van Baarsen L. G. M., Wijbrandts C. A., Rustenburg F., Cantaert T., van der Pouw Kraan T. C. T. M., Baeten D. L., Dijkmans B. A. C., Tak P. P., Verweij C. L., Regulation of IFN response gene activity during infliximab treatment in Rheumatoid Arthritis is associated with clinical response to treatment. Arthritis Research & Therapy 2010 12 1, article R11 2-s2.0-77649289297 10.1186/ar2912
243. Lübbers J., Brink M., van de Stadt L. A., The type I IFN signature as a biomarker of preclinical Rheumatoid Arthritis. Annals of the Rheumatic Diseases 2013 72 5 776 780 10.1136/annrheumdis-2012-202753
244. Tesch G., Amur S., Schousboe J. T., Siegel J. N., Lesko L. J., Bai J. P. F., Successes achieved and challenges ahead in translating biomarkers into clinical applications. The AAPS Journal 2010 12 3 243 253 2-s2.0-77955973604 10.1208/s12248-010-9182-4
245. Pirmohamed M., Acceptance of biomarker-based tests for application in clinical practice: criteria and obstacles. Clinical Pharmacology and Therapeutics 2010 88 6 862 866 2-s2.0-78449270771 10.1038/clpt.2010.245